| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.35B | 17.88B | 17.36B | 17.47B | 14.78B | 12.09B |
| Gross Profit | 2.48B | 2.31B | 1.12B | 1.81B | 1.37B | 838.20M |
| EBITDA | 2.22B | 2.01B | 987.39M | 1.58B | 619.01M | 625.05M |
| Net Income | 1.23B | 1.09B | 321.57M | 745.93M | 31.00M | 94.76M |
Balance Sheet | ||||||
| Total Assets | 9.95B | 10.65B | 9.81B | 9.26B | 8.91B | 7.47B |
| Cash, Cash Equivalents and Short-Term Investments | 612.58M | 2.05B | 697.75M | 400.99M | 427.66M | 547.62M |
| Total Debt | 3.29B | 3.47B | 3.61B | 3.53B | 3.57B | 2.57B |
| Total Liabilities | 6.40B | 6.40B | 6.47B | 6.40B | 6.32B | 4.90B |
| Stockholders Equity | 3.54B | 4.24B | 3.33B | 2.84B | 2.58B | 2.56B |
Cash Flow | ||||||
| Free Cash Flow | 829.42M | 1.51B | 134.06M | 182.75M | -55.21M | 369.49M |
| Operating Cash Flow | 1.43B | 1.99B | 677.88M | 669.86M | 326.46M | 724.25M |
| Investing Cash Flow | -590.58M | -460.80M | -503.35M | -445.25M | -1.32B | -327.00M |
| Financing Cash Flow | -2.11B | -150.91M | 116.73M | -232.01M | 901.31M | -136.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ― | ― | ― | ― | -1.19% | 78.79% | |
73 Outperform | $9.37B | 7.64 | 31.76% | ― | 1.81% | 24.67% | |
68 Neutral | $13.02B | 27.25 | 6.02% | 4.90% | 1.55% | -40.81% | |
66 Neutral | $15.49B | 9.54 | 24.20% | 9.75% | ― | 119.48% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | $8.30B | -84.31 | -1.16% | 7.87% | -5.82% | -119.70% | |
49 Neutral | $10.53B | -8.79 | -17.44% | 4.42% | -0.66% | -326.55% |
In its financial results for the third quarter ending September 28, 2025, Pilgrim’s Pride reported a year-over-year decrease in profitability, attributed to lower pricing and volume declines in certain markets. The company’s net revenue increased to $4,759.3 million from $4,585.0 million in the previous year, but net income slightly decreased to $343.1 million. The U.S. market saw a decrease in profitability due to lower pricing, while Europe and Mexico faced challenges from product mix and market prices. Despite operational improvements, the overall adjusted EBITDA margin decreased from 14.4% to 13.3%. The report also highlighted increased SG&A expenses due to legal settlements and defense costs, and a rise in net interest due to a lower cash balance following a $2 billion dividend payout.